U-HBIO

Q:HBIO - HARVARD BIOSCIENCE INC - https://www.harvardbioscience.com

02:12:21 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
HBIO - Q	0.5	0.45	·	0.558	0.1	0.4952	+0.0232	4.9	176.9	55	623	0.483 0.5061 0.4723	1.52 0.2813	17:45:54	Jan 29	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No
Financial Status: Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 623

More trades...

Time ET	Ex	Price	Change	Volume
17:45:54	Q	0.4853	0.0133	191
16:04:48	Q	0.4952	0.0232	1
16:04:21	Q	0.4952	0.0232	1
16:00:06	Q	0.4952	0.0232	1,571
16:00:06	Q	0.4952	0.0232	602
16:00:06	Q	0.4952	0.0232	1,000
16:00:06	Q	0.4952	0.0232	580
16:00:06	Q	0.4952	0.0232	3
16:00:06	Q	0.4952	0.0232	1,000
16:00:06	Q	0.4952	0.0232	162

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2026-01-29 16:30	U:HBIO	News Release200	Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
2025-12-17 07:30	U:HBIO	News Release200	Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
2025-11-06 07:00	U:HBIO	News Release200	Harvard Bioscience Announces Third Quarter 2025 Financial Results
2025-10-30 08:00	U:HBIO	News Release200	Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
2025-09-16 07:00	U:HBIO	News Release200	Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
2025-09-09 07:00	U:HBIO	News Release200	Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
2025-08-11 07:00	U:HBIO	News Release200	Harvard Bioscience Announces Second Quarter 2025 Financial Results
2025-08-04 16:30	U:HBIO	News Release200	Harvard Bioscience Schedules Second Quarter 2025 Earnings Conference Call for August 11, 2025 at 8:00 AM ET
2025-07-17 07:00	U:HBIO	News Release200	Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board
2025-06-02 16:57	U:HBIO	News Release200	Harvard Bioscience Appoints John Duke to Board of Directors
2025-05-12 07:00	U:HBIO	News Release200	Harvard Bioscience Announces First Quarter 2025 Financial Results
2025-05-05 16:45	U:HBIO	News Release200	Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
2025-04-10 16:45	U:HBIO	News Release200	Harvard Bioscience Announces CFO Transition
2025-03-12 16:00	U:HBIO	News Release200	Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
2025-03-12 07:22	U:HBIO	News Release200	Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
2025-02-24 16:45	U:HBIO	News Release200	Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
2025-02-24 11:00	U:HBIO	News Release200	Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Date ET

Symbol

Type

Headline

2026-01-29 16:30

U:HBIO

News Release

Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

2025-12-17 07:30

U:HBIO

News Release

Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package